Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271917 · ClinicalTrials.gov registry record · Phase 3
Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients
A Phase 3 study, sponsored by University of Tennessee.
- Completed
- Registry status
- Phase 3
- Development phase
- 68
- Enrollment target
NCT04271917: Completed Phase 3 study, sponsored by University of Tennessee.
NCT04271917 is a Phase 3 study that has completed, run by University of Tennessee. The registered enrollment target is 68 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04271917, a Phase 3 study, has completed, sponsored by University of Tennessee.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.
Primary Outcome
Self-report of participant's worst pain after surgery
Interventions
- DRUG placebo
- DRUG cannabidiol
- DRUG acetaminophen 500mg and ibuprofen 200mg combo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-03-31 |
| Phase | Phase 3 |
What the finished NCT04271917 record still lists
NCT04271917 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (91% lower).
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT04271917 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04271917 about?
NCT04271917 is a clinical study titled "Analgesic Effects of Cannabidiol for Simple Tooth Extractions in Dental Patients". The purpose of this study is to evaluate the analgesic effects of cannabidiol for patients who have undergone simple tooth extraction. Participants will be randomized to one of four arms: treatment-as-usual (TAU), cannabidiol 17mg/mL, cannabidiol 37mg/mL, or placebo.
What is the current status of trial NCT04271917?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 68 participants. The study started on 2020-02-24. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT04271917?
The interventions under investigation include: placebo (DRUG), cannabidiol (DRUG), acetaminophen 500mg and ibuprofen 200mg combo (DRUG).
Who is sponsoring clinical trial NCT04271917?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04271917's enrollment target sits among peer trials
68 1796th of 2000 higher than 205 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI